Global Point of Care Testing Market - Analysis and Forecast (2017-2026)

Focus on Application, Market Share, Product Mapping and Country

Published Year: 2018
SKU: BH00570SA

4599

Online Access for One Person. Permission to Print

A quick peek into the report

Report Description

The purpose of the study is to gain a holistic view of the POCT market in terms of various factors influencing it, such as recent

The global healthcare scenario is witnessing unprecedented epidemiological and demographic changes rapidly. These changes are due to the increasing geriatric population as well as the rising prevalence of diseases. As per the WHO statistics, the global elderly population (aged 65 years and over) was 562 million in 2012 and it rose by 55 million in 2015. The prevalence of various chronic and lifestyle diseases has been increasing as well. It was estimated by WHO that the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. Thus, the rising prevalence of diseases has led to increased morbidity and mortality thereby increasing the demand for better treatment and diagnostic services. Diagnosis is the very first and important step of treating any ailment. These factors have led to advancement in the field of In-Vitro Diagnostics (IVD).  With the advancement of technology, the field of IVD is evolving with the development of various devices which are minimally invasive as well as have better precision and accuracy.

The IVD tests that can be performed at or near the patient site are called as Point Of Care Testing or POCT. 

The POCT market includes product types, such as devices/ instruments, accessories/ consumables and software & other solutions. The market consists of various types of devices for different therapeutics application, such as blood glucose monitoring, infectious diseases, blood gas & electrolytes, anticoagulant management, pregnancy & fertility, substance abuse, urinalysis, cardiac markers, lipids, HbA1C, tumor/cancer markers and several others. 

These devices are being used for the rapid diagnosis of disease conditions for the early detection and management of the disease. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis. 

The purpose of the study is to gain a holistic view of the POCT market in terms of various factors influencing it, such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centered upon conducting a detailed study of the solutions allied with the POCT market. The market has been segmented into ‘product’, ‘application’, ‘end users’ and ‘geographical regions’. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global POCT market, and assesses the factors governing the same.

The key players that have been contributing significantly to the POCT market are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Instrumentation Laboratory, Trinity Biotech plc, OraSure Technologies, Alfa Scientific Designs, Radiometer, and Ascensia Diabetes Care, among others.

Key Questions Answered in this Report:

What are the major market drivers, challenges, and opportunities in the global POCT market?

•    What are the major market drivers, challenges, and opportunities in the global POCT market?
•    How did the POCT market evolve, and what is its scope in the future?
•    What are the market shares of the leading segments, and sub-segments of the global POCT market in 2017 and 2026?
•    How will each segment of the global POCT market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2026?
•    What are the influencing factors that may affect the market share of the key players?
•    What are the key developmental strategies implemented by the key players to stand out in this market?
•    What will be the growth rate of the Blood Glucose Monitoring devices during the forecast period?
•    Which product segment is expected to register the highest CAGR for the POCT market?
•    How has the market been segmented based on application? Which application segment has the largest share, and growth rate in the POCT market?
•    What is the growth rate of tumor marker POCT devices/ tests?
•    How the homecare segment among end users will grow from 2017 to 2026?
•    Which geographical location will contribute to the highest sales of the POCT devices during the forecast period?

Market Overview

The global POCT market was estimated at $13.87 billion in 2017 and is estimated to grow over $23.92 billion by 2026.

The global healthcare scenario is currently witnessing unprecedented changes owing to the rising geriatric population as well as the increasing prevalence of diseases. As per the WHO statistics, the global elderly population (aged 65 years and over) was 562 million in 2012 and it increased by 55 million in 2015. The prevalence of various chronic and lifestyle diseases has been increasing simultaneously, thus having a profound impact on the global health scenario. WHO further states that the global prevalence of diabetes, which is one of the chronic diseases, increased to 8.5% in adults over the age of 18 years in 2014, from 4.7% in 1980. This has, consequently lead to an escalated demand for better treatment and diagnostic services as diagnosis is the very first and crucial step of treating any ailment. This resulted in various developments in the field of In-Vitro Diagnostics (IVD).  With the advancement of technology, the field of IVD is evolving with the development of various devices which are minimally invasive as well as have better precision and accuracy. The IVD tests that can be performed at or near the patient site are called as Point Of Care Testing or POCT. 

The purpose of the study is to gain a holistic view of the global POCT market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centered upon conducting a detailed study of the solutions allied with the POCT market. The market has been segmented into ‘product’, ‘end-users’, ‘application’ and ‘geographical regions’. 

The global POCT market was estimated at $13.87 billion in 2017 and is estimated to grow over $23.92 billion by 2026. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for POCT devices and drive growth of the global market. The POCT devices are portable, have quick Turn Around Time (TAT) and are easy to use which makes them more attractive for the end users, thereby increasing their demand and usage.

The global POCT market can be segmented based on product into devices, consumables and software & other solutions. The major contributor to the market in 2017 was the consumables/accessories segment. Based on the application type, the market is segmented into blood glucose monitoring, infectious diseases, blood gas & electrolytes, anticoagulant management, pregnancy & fertility, substance abuse, urinalysis, cardiac markers, lipids, HbA1C, tumor/cancer markers and others. 

Based on the end users, the market can be segmented into hospitals, clinics, homecare, diagnostic laboratories and others. The market for the home care is expected to reach $5,740.2 million by 2026. Geographically, the largest contributor to the growth of the global POCT market in 2017 was North America due to the presence of supportive governmental regulations and reimbursement policies apart from the increase in the number of elderly people. This was followed by Europe. The fastest growing region was Asia-pacific because of rising healthcare expenditure and increasing patient awareness.

The PoC devices provide quick, efficient and safe detection method along with the advantage of remote and confidential testing. The market is expected to grow in the near future due to technological hybridization, connectivity with smartphone-based applications, higher demand in the developing nations, and increased usage across different indication. 

The report provides in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each. The key players for the market are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Instrumentation Laboratory, Trinity Biotech Plc, OraSure Technologies, Alfa Scientific Designs, Radiometer, and Ascensia Diabetes Care, among others.

Table of Contents

1 Market Overview

1.1.    Introduction
1.2.    IVD-Evolution of Point-of-Care testing
1.3.    Traditional vs. Point-Of-Care Testing
1.4.    Benefits of POC
1.5.    The Present Scenario
1.6.    The Future Scenario

2 Market Dynamics

2.1.    Market Drivers
2.2.    Market Challenges
2.3.    Market Opportunities

3 Industry Insights

3.1.    Regulatory Scenario
3.2.    Patent Landscape

4 Competitive Landscape

4.1.    Share of Different Strategies
4.2.    Porter's Five Force Analysis
4.3.    Market Share Analysis

5 Global Point-of-Care Testing Market, By Product

5.1.    Introduction
5.2.    Products (Devices, Consumables/Accessories and Software & other solutions)

6 Global Point Of Care Testing Market, by Application

6.1.    Introduction
6.2.     Blood Glucose Monitoring Test
6.3.    Infectious Diseases Test
6.4.    Anticoagulant Management
6.5.    Pregnancy & Fertility Testing
6.6.    Substance Abuse Test
6.7.    Blood Gas & Electrolyte Test
6.8.    Urinalysis
6.9.    Cardiac Markers
6.10.    HbA1C
6.11.    Lipids
6.12.    Tumor/Cancer Markers
6.13.    Others

7 Global Point Of Care Testing Market, By End User

7.1.    Introduction
7.2.    Type of End Users (Hospitals, Clinics, Home Care, Diagnostic Laboratories & others)

8 Global Point Of Care Testing Market, by Region

8.1.    Introduction
8.2.    North America
          8.2.1.    The U.S.
          8.2.2.    Canada
8.3.    Europe
          8.3.1.    Germany
          8.3.2.    France
          8.3.3.    Italy
          8.3.4.    The U.K.
          8.3.5.    Spain
          8.3.6.    Netherlands
          8.3.7.    Belgium
          8.3.8.    Rest of Europe
8.4.    Asia Pacific
          8.4.1.    Japan
          8.4.2.    China
          8.4.3.    Australia
          8.4.4.    South Korea
          8.4.5.    India
          8.4.6.    Rest of Asia Pacific
8.5.    Latin America
          8.5.1.    Brazil
          8.5.2.    Mexico
          8.5.3.    Rest of Lain America
8.6.    Rest of the World (RoW)
          8.6.1.    MENA
          8.6.2.    Russia
          8.6.3.    Rest of RoW

9 Company Profiles

9.1.    Abaxis, Inc.
9.1.1.    Overview
9.1.2.    Overall Product Portfolio
9.1.3.    Product Offerings for POC Market
9.1.4.    Financials
9.1.4.1.    Financial Summary
9.1.5.    Global Presence
9.1.6.    Recent Developments
9.1.7.    Abaxis Inc.: SWOT Analysis
9.2.    Abbott Laboratories
9.2.1.    Overview
9.2.2.    Overall Product Portfolio
9.2.3.    Product Offerings for POC Market
9.2.4.    Financials
9.2.4.1.    Financial Summary
9.2.5.    Global Presence
9.2.6.    Recent Developments
9.2.7.    Abbott Laboratories: SWOT Analysis
9.3.     Alfa Scientific Designs, Inc.
9.3.1.    Overview
9.3.2.    Corporate Summary
9.3.3.    Product Offerings for POC Market
9.3.4.    Recent Developments
9.3.5.    Alfa Scientific Designs, Inc.: SWOT Analysis
9.4.     ARKRAY, Inc.
9.4.1.    Overview
9.4.2.    Corporate Summary
9.4.3.    Product Offerings for POC Market
9.4.4.    Recent Developments
9.4.5.    ARKRAY, Inc.: SWOT Analysis
9.5.    Ascencia  Diabetes Care Holdings AG
9.5.1.    Overview
9.5.2.    Parent Company Overview: Panasonic Healthcare Holdings Co., Ltd.
9.5.3.    Corporate Summary
9.5.4.    Product Offerings for POC Market
9.5.5.    Recent Developments
9.5.6.    Ascencia Diabetes Care Holdings AG: SWOT Analysis
9.6.    Beckman Coulter
9.6.1.    Overview
9.6.2    Parent Company Overview: Danaher Corporation
9.6.3.    Overall Product Portfolio: Danaher Corporation
9.6.4.    Product Offerings for POC Market
9.6.5.    Financials: Danaher Corporation
9.6.5.1.    Financial Summary: Danaher Corporation
9.6.6.    Global Presence: Danaher Corporation
9.6.7.    Recent Developments: Danaher Corporation
9.6.8.    Danaher Corporation: SWOT Analysis
9.7.    Becton Dickinson and Company
9.7.1.    Overview
9.7.2.    Overall Product Portfolio
9.7.3.    Product Offerings for POC Market
9.7.4.    Financials
9.7.4.1.    Financial Summary
9.7.5.    Global Presence
9.7.6.    Recent Developments
9.7.7.    Becton Dickinson and Company: SWOT Analysis
9.8.    bioMerieux SA
9.8.1.    Overview
9.8.2.    Overall Product Portfolio
9.8.3.    Product Offerings for POC Market
9.8.4.    Financials
9.8.4.1.    Financial Summary
9.8.5.    Global Presence
9.8.6.    Recent Developments
9.8.7.    bioMerieux SA: SWOT Analysis
9.9.    CHEMBIO DIAGNOSTICS, INC.
9.9.1.    Overview
9.9.2.    Overall Product Portfolio
9.9.3.    Product Offerings for POC Market
9.9.4.    Financials
9.9.4.1.    Financial Summary
9.9.5.    Global Presence
9.9.6.    Recent Developments
9.9.7.    CHEMBIO DIAGNOSTICS, Inc.: SWOT Analysis
9.10.    F. Hoffmann-La Roche AG
9.10.1.    Overview
9.10.2.    Overall Product Portfolio
9.10.3.    Product Offerings for POC Market
9.10.4.    Financials
9.10.4.1.    Financial Summary
9.10.5.    Global Presence
9.10.6.    Recent Developments
9.10.7.    F. Hoffmann-La Roche AG: SWOT Analysis
9.11.    Instrumentation Laboratory
9.11.1.    Overview
9.11.2.    Corporate Summary
9.11.3.    Product Offerings for POC Market
9.11.4.    Recent Developments
9.11.5.    Instrumentation Laboratories: SWOT Analysis
9.12.    LamdaGen Corporation
9.12.1.    Overview
9.12.2.    Corporate Summary
9.12.3.    Product Offerings for POC Market
9.12.4.    Recent Developments
9.12.5.    LamdaGen Corporation: SWOT Analysis
9.13.    Medtronic Public Limited Company
9.13.1.    Overview
9.13.2.    Overall Product Portfolio
9.13.3.    Medtronic Public Limited Company: Product Portfolio
9.13.4.    Financials
9.13.4.1.    Financial Summary
9.13.5.    Global Presence
9.13.6.    Recent Developments
9.13.7.    Medtronic Public Limited Company: SWOT Analysis
9.14.    Nova Biomedical
9.14.1.    Overview
9.14.2.    Corporate Summary
9.14.3.    Product Offerings for POC Market
9.14.4.    Recent Developments
9.14.5.    Nova Biomedical: SWOT Analysis
9.15.    OraSure Technologies, Inc.
9.15.1.    Overview
9.15.2.    Overall Product Portfolio
9.15.3.    Product Offerings for POC Market
9.15.4.    Financials
9.15.4.1.    Financial Summary
9.15.5.    Global Presence
9.15.6.    Recent Developments
9.15.7.    OraSure Technologies, Inc.: SWOT Analysis
9.16.    RADIOMETER
9.16.1.    Overview
9.16.2.    Corporate Summary
9.16.3.    Product Offerings for POC Market
9.16.4.    Recent Developments
9.16.5.    RADIOMETER: SWOT Analysis
9.17.    Siemens Healthineers
9.17.1.    Overview
9.17.2.    Parent Company Overview: Siemens
9.17.3.    Overall Product Portfolio of Siemens
9.17.4.    Product Offerings for POC Market
9.17.5.    Financials (Siemens)
9.17.5.1.    Financial Summary (Siemens)
9.17.6.    Global Presence (Siemens)
9.17.7.    Recent Developments
9.17.8.    Siemens: SWOT Analysis
9.18.    Trinity Biotech plc
9.18.1.    Overview
9.18.2.    Overall Product Portfolio
9.18.3.    Product Offerings for POC Market
9.18.4.    Financials
9.18.4.1.    Financial Summary
9.18.5.    Global Presence
9.18.6.    Recent Developments
9.18.7.    Trinity Biotech plc: SWOT Analysis
9.19.    CALYPTE BIOMEDICAL CORPORATION
9.19.1.    Overview
9.19.2.    Product Offerings for POC Market
9.20.     LifeScan, Inc.
9.20.1.    Overview
9.20.2.    Product Offerings for POC Market
9.21.    Mologic
9.21.1.    Overview
9.21.2.    Product Offerings for POC Market
9.22.    PTS Diagnostics
9.22.1.    Overview
9.22.2.    Product Offerings for POC Market
9.23.    Sinocare Inc.
9.23.1.    Overview
9.23.2.    Product Offerings for POC Market

10 Report Scope

10.1    Scope of the Report
10.2    Global POCT Market Segmentation
10.3    Research Methodology
           10.3.1.    Data Triangulation
           10.3.2.    Key Data Points From Secondary Sources 
           10.3.3.    Key Data Points From Primary Sources 
           10.3.4.    Top-Down  Approach (Segmental Analysis)
           10.3.5.    Bottom-Up Approach (Segmental Analysis)
           10.3.6.    Data and Prediction Modelling
10.4.    Assumptions and Limitations

List of Tables

1    Global POCT Market (2017 & 2026)
2     Total Regional Geriatric Population by Region (%), 2015 and 2030
3    Some Examples of POCT Products
4    Global Regulatory Scenario
5    Risk Associated with Cholesterol Levels
6    Some of Common Cancer Markers
7    Percentage of population aged 60 years or above
8    Percentages of population aged 60 or over.
9    Percentages of population aged 60 or over.
10    Abaxis, Inc.:Overview
11    Abaxis, Inc.: Recent Developments
12    Abbott Laboratories:Overview
13    Abbott Laboratories: Recent Developments
14    Alfa Scientific Designs, Inc.:Overview
15    Alfa Scientific Designs, Inc: Recent Developments
16    ARKRAY, Inc.: Overview
17    ARKRAY, Inc: Recent Developments
18    Ascensia Diabetes Care Holdings AG.: Overview
19    Ascensia Diabetes Care Holdings AG: Parent Company Overview: Panasonic Healthcare Holdings Co., Ltd.
20    Ascensia Diabetes Care Holdings AG: Recent Developments
21    Beckman Coulter: Overview
22    Beckman Coulter: Parent Company Overview: Danaher Corporation
23    Danaher Corporation: Recent Developments
24    Becton Dickinson  and Company: Overview
25    Becton Dickinson and Company: Recent Developments
26    bioMerieux SA: Overview
27    bioMerieux SA: Recent Developments
28    CHEMBIO DIAGNOSTICS, Inc.: Overview
29    CHEMBIO DIAGNOSTICS, Inc.: Recent Developments
30    F.Hoffmann-La Roche AG: Overview
31    Instrumentation Laboratory: Overview
32    Instrumentation Laboratory: Recent Developments
33    Medtronic Public Limited Company: Overview
34    Medtronic Public Limited Company: Recent Developments
35    Nova Biomedical: Overview
36    Nova Biomedical: Recent Developments
37    OraSure Technologies: Overview
38    OraSure Technologies: Recent Developments
39    RADIOMETER: Overview
40    RADIOMETER: Recent Developments
41    Siemens Healthineers:Overview
42    Siemens Healthineers: Parent Company Overview: Siemens
43    Siemens: Recent Developments
44    Trinity Biotech plc: Overview
45    Trinity Biotech plc: Recent Developments
46    CALYPTE BIOMEDICAL CORPORATION: Overview
47    LifeScan, Inc.: Overview
48    Mologic: Overview
49    PTS Diagnostics:Overview
50    Sinocare Inc.: Overview

List of Figures

1    Point Of Care Testing: Part of IVD
2    Global Point Of Care Testing Market ($Billion)
3    Medical Device Connectivity
4    Key Trends & Opportunities for Future
5    Chronic Conditions: Key Statistics: 2016
6    Global POCT Market, by Product, 2017
7    Global POCT Market, by Product, 2026
8    Global POCT Market, by Application, 2017
9    Global POCT Market, by Application, 2026
10    Global POCT Market Value, by Region, 2017 & 2026 ($Billion)
11    Global POCT Market, by Region, 2017
12    Global POCT Market, by Region, 2026
13    Technological Advancements
14    Key players of POCT Market
15    Features of POC devices
16    Market segmentation of In vitro diagnostics
17    Traditional Laboratory testing Procedure
18    Advantages of Point-of-care Testing
19    End-users of POCT 
20    Share of Different Key Strategies
21    Porter’s Five Forces Analysis
22    Types of Products
23    Global POCT Market, by Product, 2016-2026, ($ Millions)
24    Global Point-of-Care Testing Market, by Application
25    Global Point Of Care Testing Market, by Application, 2017-2026 ($Million)
26    Types of Diabetes Mellitus
27    Rise in Diabetes cases
28    Global Blood Glucose Monitoring Test Market, 2017-2026, ($ Millions)
29    Global Infectious Diseases Test Market, 2017-2026, ($ Millions)
30    Global Infectious Diseases Test Market, by Type 2017-2026, ($ Millions)
31    Global Anticoagulant Management Test Market, 2017-2026, ($ Millions)
32    Global Pregnancy & Fertility Testing Market, 2017-2026, ($ Millions)
33    Global Substance Abuse POCT Market, 2016-2026, ($ Millions)
34    Global Blood Gas & Electrolytes POCT Market, 2017-2026, ($ Millions)
35    Global Urinalysis POCT Market, 2016-2026, ($ Millions)
36    Deaths due to CVD
37    Global Cardiac Markers POCT Market, 2017-2026, ($ Millions)
38    Global HbA1C POCT Market, 2017-2026, ($ Millions)
39    Global Lipids POCT Market, 2017-2026, ($ Millions)
40    Global Tumor/Cancer Marker POCT Market, 2017-2026, ($ Millions)
41    Global Others POCT Market, 2017-2026, ($Millions)
42    Different End Users For The Point Of Care Testing
43    Global POCT Market, by End User, 2016-2026, ($ Millions)
44    Global Point Of Care Testing Market, By Region
45    Global POCT Market, by region 2016-2025 ($Billion)
46    North America POCT Market, 2017-2026 ($Million)
47    North America POCT Market, by Country, 2016-2026 ($Million)
48    The U.S. POCT Market, 2016-2025 ($Million)
49    Canada POCT Market, 2016-2026 ($Million)
50    Europe POCT Market, 2017-2026 ($Million)
51    Europe POCT Market, by Country, 2017-2026 ($Million)
52    Germany POCT Market, 2017-2026 ($Million)
53    France POCT Market, 2017-2026 ($Million)
54    Italy POCT Market, 2017-2026 ($Million)
55    The U.K. POCT Market, 2017-2026 ($Million)
56    Spain POCT Market, 2017-2026 ($Million)
57    Netherlands POCT Market, 2017-2026 ($Million)
58    Belgium POCT Market, 2017-2026 ($Million)
59    Rest of Europe POCT Market, 2017-2026 ($Million)
60    Asia Pacific POCT Market, 2017-2026 ($Million)
61    Asia Pacific POCT Market, by Country, 2017-2026 ($Million)
62    Japan POCT Market, 2017-2026 ($Million)
63    China POCT Market, 2017-2026 ($Million)
64    Australia POCT Market, 2017-2026 ($Million)
65    South Korea POCT Market, 2017-2026 ($Million)
66    India POCT Market, 2017-2026 ($Million)
67    Rest of Asia Pacific POCT Market, 2017-2026 ($Million)
68    Latin America POCT Market, 2017-2026 ($Million)
69    Latin America POCT Market, by Country, 2017-2026 ($Million)
70    Prevalence of Diabetes in Brazil & Mexico
71    Brazil POCT Market, 2017-2026 ($Million)
72    Mexico POCT Market, 2017-2026 ($Million)
73    Rest of Latin America POCT Market, 2017-2026 ($Million)
74    RoW POCT Market, 2017-2026 ($Million)
75    RoW POCT Market, by Country, 2017-2026 ($Million)
76    Rising Prevalence of Diabetes
77    MENA POCT Market, 2017-2026 ($Million)
78    Russia POCT Market, 2017-2026 ($Million)
79    Rest of RoW POCT Market, 2017-2026 ($Million)
80    Abaxis, Inc.: Product Portfolio
81    Abaxis, Inc.: Product Portfolio for POC Market
82    Abaxis, Inc.: Overall Financials (2014-2017)
83    Abaxis, Inc.: Net Revenue by Business Segment (2014-2017)
84    Abaxis, Inc.: Product Sales by Region (2014-2017)
85    Abaxis, Inc.: Global Presence
86    Abaxis, Inc.: SWOT Analysis
87    Abbott Laboratories: Product Portfolio
88    Abbott Laboratories: Product Portfolio for POC Market
89    Abbott Laboratories: Overall Financials (2014-2016
90    Abbott Laboratories: Revenue by Business Segment (2014-2016
91    Abbott Laboratories: Revenue by Region (2014-2016)
92     Abbott Laboratories: Global Presence
93    Abbott Laboratories:  SWOT Analysis
94    Alfa Scientific Designs, Inc.: Overall Product Portfolio
95    Alfa Scientific Designs, Inc.: Product Portfolio for POC Market
96    Alfa Scientific Designs, Inc. :SWOT Analysis
97    ARKRAY, Inc.: Overall Product Portfolio
98    ARKRAY, Inc.: Product Portfolio for POC Market
99    ARKRAY, Inc : SWOT Analysis
100    Ascensia Diabetes Care Holdings AG: Overall Product Portfolio
101    Ascensia Diabetes Care Holdings AG: Product Portfolio for POC Market
102    Ascensia Diabetes Care Holdings AG :SWOT Analysis
103    Danaher Corporation: Product Portfolio
104    Beckman Coulter: Product Portfolio for POC Market
105    Danaher Corporation: Overall Financials (2014-2016)
106    Danaher Corporation: Revenue by Business Segments (2014-2016)
107    Danaher Corporation: Revenue by Region (2014-2016)
108    Danaher Corporation: Global Presence
109    Danaher Corporation :SWOT Analysis
110    Becton Dickinson & Company: Product Portfolio
111    Becton Dickinson and Company: Product Portfolio for POC Market
112    Becton, Dickinson and Company : Overall Financials (2014-2017)
113    Becton, Dickinson and Company: Product Sales by Region (2014-2017)
114    Becton, Dickinson and Company: Revenue by Business Segment (2014-2017)
115    Becton, Dickinson and Company: Revenue by Sub-Segment  (2014-2017)
116    Becton Dickinson and Company: Global Presence
117    Becton Dickinson and Company : SWOT Analysis
118    bioMerieux SA: Product Portfolio
119    bioMerieux SA: Product Portfolio for POC Market
120    bioMerieux SA: Overall Financials (2014-2016)
121    bioMerieux SA: Revenue by Business Segment (2014-2016)
122    bioMérieux SA: Net revenue by Region (2014-2016)
123    bioMerieux SA: Global Presence
124    bioMerieux SA : SWOT Analysis
125    CHEMBIO DIAGNOSTICS, Inc.: Product Portfolio
126    CHEMBIO DIAGNOSTICS, Inc.: Product Portfolio for POC Market
127    Chembio Diagnostic Systems, Inc.: Overall Financials (2014-2016)
128    Chembio Diagnostic Systems, Inc.: Product Sales by Region (2014-2016)
129    CHEMBIO DIAGNOSTICS, Inc.: Global Presence
130    CHEMBIO DIAGNOSTICS, Inc. SWOT Analysis
131    F.Hoffmann-La Roche AG: Product Portfolio
132    F. Hoffmann-La Roche AG: Product Portfolio for POC Market
133    F.Hoffmann-La Roche AG : Overall Financials (2014-2017)
134    F.Hoffmann-La Roche AG : Product Sales by Region (2014-2017)
135    F.Hoffmann-La Roche AG: Revenue by Division (2014-2017)
136    F.Hoffmann-La Roche Ag: Revenue By Diagnostics Sub-division (2014-2017)
137     F. Hoffmann-La Roche AG: Global Presence
138     F. Hoffmann-La Roche AG: Recent Developments
139    F. Hoffmann-La Roche AG: SWOT Analysis
140    Instrumentation Laboratory: Overall Product Portfolio
141    Instrumentation Laboratory: Product Portfolio for POC Market
142    Medtronic Public Limited Company: Overall Product Portfolio
143    Medtronic Public Limited Company: Product Portfolio for POC market
144    Medtronic plc: Overall Financials (2014-2017)
145    Medtronic plc: Net Revenue by Business Segment (2014-2017)
146    Medtronic plc: Net Revenue by Region (2014-2017)
147    Medtronic Public Limited Company: Global Presence
148    Medtronic Public Limited Company: SWOT Analysis
149    Nova Biomedical: Overall Product Portfolio
150    Nova Biomedical: Product Portfolio for POC Market
151    Nova Biomedical : SWOT Analysis
152    Orasure Technologies, Inc.: Product Portfolio
153    OraSure Technologies, Inc.: Product Portfolio for POC Market
154    OraSure Technologies, Inc.: Overall Financials (2014-2016)
155    OraSure Technologies, Inc.: Net Revenue by Business Segment (2014-2016)
156    OraSure Technolgies, Inc.: Product Sales by Region (2015-2017)
157    OraSure Technologies, Inc.: Global Presence
158    OraSure Technologies:  SWOT Analysis
159    RADIOMETER: Overall Product Portfolio
160    RADIOMETER: Product Portfolio for POC Market
161    RADIOMETER : SWOT Analysis
162    Siemens: Product Portfolio
163    Product Portfolio of Siemens Healthineers for POC Market
164    Siemens : Overall Financials (2014-2017)
165    Siemens: Product Sales by Region (2014-2017)
166    Siemens, Inc.: Net Revenue by Business Segment (2014-2017)
167    Siemens Healthineers: Global Presence
168    Siemens: SWOT Analysis
169    Trinity Biotech plc: Product Portfolio
170    Trinity Biotech plc: Product Portfolio for POC Market
171    Trinity Biotech plc: Overall Financials (2014-2016)
172    Trinity Biotech plc: Net Revenue by Product Line (2014-2016)
173    Trinity Biotech plc: Product Sales by Region (2014-2016)
174    Trinity Biotech plc: Global Presence
175    Trinity Biotech plc: SWOT Analysis
176    CALYPTE BIOMEDICAL CORPORATION: Product Portfolio
177    LifeScan, Inc.: Product Portfolio
178    Mologic: Product Portfolio
179    PTS Diagnostics: Product Portfolio
180    Sinocare Inc.: Product Portfolio
181    Global POCT Market Segmentation

Table
of Contents

Request a Sample

You may also like

Published Year: 2017

Global IVD(In-Vitro Diagnostics) Market - Analysis and Forecast 2017-2023: (Focus on Product Type, Test Type, Application, and Competitive Landscape)

IVD is expected to increase to $76 billion by 2023 and increase its influence over healthcare...

 

Global Point of Care Testing Market - Analysis and Forecast (2017-2026)

Focus on Application, Market Share, Product Mapping and Country